asa guidelines for glp-1 agonists glp 1 Receptor Agonists in Gastrointestinal Practices: Enhancing Both Procedural and Patient-Related Outcomes Perioperative anesthesia management of GLP-1

Nausea Constipation Diarrhea Vomiting Indigestion Stomach pain Headache Bloating of stomach Fatigue Belching Gastroesophageal reflux disease Flatulence Hair loss You are encouraged to report negative side effects of prescription products to the FDA

FDA safety concerns The FDA has been vocal about safety concerns regarding compounded GLP-1 medications

In general, I think its a good thing that there are new tools available for patients with obesity, which increases the risk of heart disease, diabetes, many forms of cancer and early death

A separate survey released in May by the Business Group on Health, a Washington, D.C.-based nonprofit focused on employer healthcare policy, found that 67% of employers cover GLP-1 drugs for weight management, though many impose conditions aimed at limiting their use or ensuring clinical oversight

Ghusn, W